TORE FLAVIN: Open Payments
NPI 1427680693 · HILTON HEAD ISLAND, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$566 in 22 payments from 13 companies in 2025. Trend: 2023 $1,937 · 2024 $2,207 · 2025 $566
Food & beverage: $546Education: $21
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $135 |
| Celgene Corporation | 5 | $107 |
| Merck Sharp & Dohme LLC | 3 | $76 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Pharmacosmos Therapeutics Inc. | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Geron Corporation | 1 | $20 |
Products named: RYBREVANT, REBLOZYL, KEYTRUDA, LIBTAYO, KISQALI, MONOFERRIC, Enhertu, OPDIVO.
Industry payments across SC — which companies pay providers there.
